Humana Inc. HUM

Humana posted FY revenue of $144B, up 11.2% YoY, and our econometric model flags efficient SG&A as a key growth lever, with SG&A generating $3.46 in revenue per $1 spent. That ROI implies growth derives from smarter marketing and enrollment management—primarily Medicare Advantage enrollment and persistency—rather than aggressive price hikes. Holdout testing shows the model forecast $33.4B vs actual $32.5B (2.6% error), while overall MAPE runs at 2.5%, underscoring solid reliability but exposure to policy or competitive shifts. At roughly 11%, the pace heightens regulatory and margin risk if MA payments or risk adjustments tighten, making continued SG&A efficiency and favorable enrollment economics critical to sustaining the growth trajectory.